Evidence map›Paper›PMID 39579743›Full record

ArticleEuropean journal of obstetrics, gynecology, and reproductive biology2025

Case-control study of clotting differences using ROTEM testing in pregnant patients with early vaginal bleeding.

Patrick Maher, Dan Katz, Omara Afzal, Sylviah Nyamu, Lynne D Richardson

Abstract read
In one paragraph

Article in European journal of obstetrics, gynecology, and reproductive biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Patrick MaherDepartment of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: patrick.maher@mountsinai.org.
Dan KatzDepartment of Anesthesiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: daniel.katz@mountsinai.org.
Omara AfzalDepartment of Obstetrics and Gynecology, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: oafzal@capitalhealth.org.
Sylviah NyamuDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, United States. Electronic address: swn2104@cumc.columbia.edu.
Lynne D RichardsonDepartment of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: lynne.richardson@mountsinai.org.

Funding

Mount Sinai Clinician Scientist Training Program in Emergency Care ResearchT32HL129974 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI RICHARDSON, LYNNE D. · 2016 to 2020
$2.3M
Mount Sinai Clinician Scientist Training Program in Emergency Care ResearchT32HL160513 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Lynne D. Richardson · 2022 to 2026
$2.2M
NHLBI NIH HHS T32 HL129974NHLBI NIH HHS T32 HL160513
6 · The paper itself

Abstract

backgroundVaginal bleeding in early pregnancy is a common presentation in the Emergency Department (ED), often resulting in pregnancy loss. Hypercoagulability exceeding normal physiological changes may be associated with miscarriage, but conventional clotting tests do not reliably detect this effect. Rotational thromboelastometry (ROTEM), which performs a more comprehensive clotting evaluation, may demonstrate coagulopathic abnormalities contributing to vaginal bleeding and miscarriage in early pregnancy that are not present in normal gestation.

objectiveThis study aimed to evaluate the relationship between coagulation results from ROTEM testing in patients undergoing active evaluation for possible miscarriage compared to samples taken from asymptomatic patients with healthy pregnancies. STUDY

designThis was a prospective case control study from a single center. Patients with chief complaint of vaginal bleeding in early pregnancy (less than 20 weeks) were recruited from the ED for ROTEM testing. These results were compared to healthy pregnant women presenting for routine prenatal care at our hospital's obstetrical clinic. Crude results were analyzed using t-test for ROTEM measures, and differences were then compared using multiple linear regression, controlling for patient age, race, ethnicity, number of prior pregnancies, and estimated gestational age (EGA) in weeks. ROTEM measurements of interest were the clot formation kinetics using EXTEM, INTEM, and NATEM tracings.

resultsOver the study, 46 patients were recruited from the ED and 51 from the obstetric clinic. Both groups had similar mean ages, and racial and ethnic distribution. ED patients had earlier EGA than OB clinic patients, 7.6 weeks vs. 10.7 weeks, but higher patient age and higher number of prior pregnancies. ROTEM results were not significantly different between groups on univariate analysis except for INTEM CFT and INTEM MCF. After controlling for the patient age and estimated gestational age, no ROTEM result differed between groups.

conclusionIn pregnant patients presenting to the ED with vaginal bleeding before 20 weeks, ROTEM differences were not different in comparison to healthy pregnant patients at the same gestation stage. This suggests that ROTEM clotting profiles may not be useful in the evaluation of vaginal bleeding within this population.

Indexed as

ThrombelastographyUterine HemorrhageAbortion, SpontaneousAdultBlood CoagulationCase-Control StudiesFemaleHumansPregnancyPregnancy Complications, HematologicProspective StudiesYoung AdultAbortionEmergency departmentHypercoagulabilityMiscarriageViscoelastic testing

Identifiers

PMID39579743
PMCPMC11634626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.